Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
291 |
|
| Actual shortage: | 4 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (5%) | |
| Resolved: | 271 (93%) | |
Discontinuation Reports |
61 |
|
| To be discontinued: | 7 (11%) | |
| Discontinued: | 53 (87%) | |
| Reversed: | 1 (2%) | |
Late reports |
21 (6%) |
|
Overdue reports |
4 (36%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| KEVZARA | 200MG | SOLUTION | Resolved | 2023-03-31 | 2023-04-04 | 188465 |
| KEVZARA | 150MG | SOLUTION | Resolved | 2022-04-22 | 2022-08-26 | 159316 |
| KEVZARA | 150MG | SOLUTION | Resolved | 2023-01-18 | 2023-03-15 | 181429 |
| KEVZARA | 150MG | SOLUTION | Resolved | 2023-04-12 | 2023-08-16 | 189382 |
| KEVZARA | 200MG | SOLUTION | Resolved | 2020-02-21 | 2022-07-20 | 106826 |
| KEVZARA | 200MG | SOLUTION | Resolved | 2022-03-01 | 2022-05-31 | 155759 |
| KEVZARA | 200MG | SOLUTION | Resolved | 2022-11-17 | 2023-02-11 | 175209 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2021-05-03 | 2021-05-11 | 138648 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2022-02-02 | 2022-09-14 | 154110 |
| LANTUS | 100UNIT | SOLUTION | Avoided shortage | 2021-04-22 | 2021-05-10 | 137925 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2022-01-21 | 2022-09-14 | 153349 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2023-01-26 | 2023-02-09 | 182411 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2023-03-13 | 2023-03-25 | 187015 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2023-12-20 | 2024-02-23 | 213961 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2025-06-16 | 2025-07-05 | 260407 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2022-01-13 | 2022-01-27 | 152697 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2022-01-28 | 2022-09-14 | 153853 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2022-12-20 | 2023-01-12 | 179011 |
| LANTUS | 100UNIT | SOLUTION | Resolved | 2023-12-20 | 2024-02-13 | 213964 |
| LASIX ORAL SOLUTION | 10MG | SOLUTION | Resolved | 2023-11-17 | 2023-11-23 | 210570 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PEDIAPRED | 5MG | SOLUTION | Discontinued | 2023-09-28 | 2023-12-19 | 205412 |
| PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
| PLAVIX | 300MG | TABLET | To be discontinued | 2019-12-11 | 2019-12-11 | 100941 |
| RENVELA | 0.8G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239433 |
| RENVELA | 2.4G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239436 |
| RENVELA | 800MG | TABLET | Reversed | 2025-03-31 | 2025-09-26 | 253680 |
| RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
| RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
| RIFATER | 300MG 120MG 50MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3688 |
| SECTRAL | 400MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3692 |
| SECTRAL | 200MG | TABLET | Discontinued | 2018-07-09 | 2018-09-07 | 54767 |
| SECTRAL | 100MG | TABLET | Discontinued | 2018-09-17 | 2018-10-03 | 61609 |
| TALWIN | 50MG | TABLET | Discontinued | 2020-11-09 | 2021-02-06 | 128146 |
| TALWIN | 50MG | TABLET | Discontinued | 2021-02-09 | 2021-02-09 | 133620 |
| TAXOTERE | 20MG | SOLUTION | Discontinued | 2018-02-23 | 2018-05-28 | 40870 |
| TAXOTERE | 80MG | SOLUTION | To be discontinued | 2018-06-27 | 2018-10-17 | 53064 |
| TUSSIONEX | 5MG 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-08-17 | 2017-08-22 | 19700 |
| TUSSIONEX | 5MG 10MG | SUSPENSION | Discontinued | 2019-11-11 | 2020-03-24 | 98368 |
| ZALTRAP | 100MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121387 |
| ZALTRAP | 200MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121390 |